Form 4: enGene Holdings Director Richard Glickman Reports Acquisition of 22,500 Stock Options

enGene Holdings Inc. Director and 10% Owner Richard M. Glickman reported the acquisition of 22,500 stock options with an exercise price of $3.31, which will fully vest by the earlier of June 10, 2026, or the 2026 Annual Meeting of Shareholders.

Summary

• Richard M. Glickman, a Director and 10% Owner of enGene Holdings Inc. (ENGN), acquired 22,500 stock options.
• The options have an exercise price of $3.31 per share.
• The transaction date for the acquisition was June 16, 2025.
• These options are set to fully vest on the earlier of June 10, 2026 (one year from vesting commencement date of June 10, 2025) or the 2026 Annual Meeting of Shareholders.
• The options have an expiration date of June 16, 2035.
• Following this transaction, Mr. Glickman directly beneficially owns 22,500 derivative securities (stock options).

Sentiment

Score: 6

Explanation: Slightly positive. The acquisition of stock options by a director and 10% owner indicates alignment of interests and potential confidence in future stock performance, although it's a standard compensation event.

Positives

• The acquisition of stock options by a Director and 10% Owner, Richard M. Glickman, indicates alignment of interests between management and shareholders, as his future compensation is tied to the company's stock performance.
• The exercise price of $3.31 provides a clear target for stock appreciation for the options to be in-the-money.

Negatives

• No direct negatives are apparent from this Form 4 filing, as it primarily reports an insider's acquisition of stock options as part of compensation.

Risks

• The value of the stock options is dependent on the future market price of enGene Holdings Inc. common shares. If the share price does not exceed the exercise price of $3.31, the options may expire worthless.
• The vesting schedule ties the options to future performance and continued service, meaning the options are not immediately exercisable.

Future Outlook

The acquired stock options are subject to a vesting schedule, indicating that they will fully vest on the earlier of June 10, 2026, or the 2026 Annual Meeting of Shareholders, aligning the director's incentives with future company performance.

Industry Context

Insider transactions, such as the acquisition of stock options by a director, are common practices in publicly traded companies for executive and board compensation. These filings provide transparency into how company insiders' interests are aligned with shareholder value creation, often signaling confidence in the company's future prospects, especially when options are granted at a specific exercise price.

Stakeholder Impact

• Shareholders: May view the director's acquisition of options as a positive signal, indicating management's vested interest in increasing shareholder value.

Next Steps

• The stock options will continue to vest according to the specified schedule.
• Richard M. Glickman may choose to exercise these options once they are vested and if the stock price is favorable.

Key Dates

Keywords

enGene Holdings Inc., ENGN, SEC Form 4, Insider Transaction, Stock Options, Richard M. Glickman, Director, 10% Owner, Beneficial Ownership, Equity Compensation